-
-
Call more information
660-596-2224 -
Author: Paul Owers, Florida Atlantic University Medical X press The health care industry’s trend toward making care more consumer-driven and patient-centered by transferring risk and control to patients is actually placing more stress on those who work on the front lines, particularly in light of COVID-19, say researchers from Florida Atlantic University and four other […]
Read MoreAuthor: ROBERT PREIDT HealthDay News There’s more bad news about electronic cigarettes: Researchers have identified previously unknown toxins that can affect the heart and lungs of those who vape. The chemicals form when manufacturers combine flavorings with solvents in e-cigarettes, according to the study. These chemicals can irritate the airways and trigger reactions that result […]
Read MoreDG Alerts A study published in the Journal of General Internal Medicine found that return to hospital after admission for coronavirus disease 2019 (COVID-19) was infrequent within 14 days of discharge and respiratory distress was the most common cause for return. Further, returning patients were more likely to have a history of chronic obstructive pulmonary disease (COPD) […]
Read MoreDG Alerts Research findings published in the Journal of Medical Virology point to anaemia being an independent risk factor tied to severe coronavirus disease 2019 (COVID‐19), with Zheying Tao, Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, and colleagues, calling for healthcare professionals to “be more sensitive to the […]
Read MoreAuthor: Alan Mozes HealthDay News Placing a hospitalized COVID-19 patient in a face down position to ease breathing — or “proning” — has steadily gained traction as a pandemic lifesaver. But a small new study warns that it may lead to permanent nerve damage. The concern is based on the experience of 83 COVID-19 patients […]
Read MoreDG Alerts The US Food and Drug Administration (FDA) has approved oliceridine (Olinvyk), an opioid agonist, for the management of moderate-to-severe acute pain in adults, where the pain is severe enough to require an intravenous (IV) opioid and for whom alternative treatments are inadequate. Oliceridine is indicated for short-term IV use in hospitals or other […]
Read MoreDG Alerts Findings from a UK study published in The Lancet Oncology indicate that cancer patients with different tumour types have variable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptibility and coronavirus disease 2019 (COVID-19) phenotypes. In particular, patients with haematological cancers (leukaemia, lymphoma, or myeloma) had increased susceptibility to the virus, and were at greater risk […]
Read MoreDG Alerts According to data from an open-label Phase III study published in the Journal of the American Medical Association, patients with moderate coronavirus disease 2019 (COVID-19) pneumonia randomized to receive remdesivir treatment for up to 5 days had significantly higher odds of achieving clinical improvement at the 11-day mark than those receiving standard care. However, […]
Read MoreAuthor: Michael Walter Cardiovascular Business News Antihypertensive medications can improve COVID-19 survival rates and reduce the likelihood of severe illness, according to a new meta-analysis published in Current Atherosclerosis Reports. The study’s authors explored data from 19 different studies, focusing on the impact of renin-angiotensin-aldosterone system (RAAS) inhibitors such as angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-receptor […]
Read MoreI want to thank all of our readers a fun and happy labor day. Please be safe
Read More